134 related articles for article (PubMed ID: 12687013)
1. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
[TBL] [Abstract][Full Text] [Related]
2. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
3. A role for mismatch repair in control of DNA ploidy following DNA damage.
Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R
Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940
[TBL] [Abstract][Full Text] [Related]
4. Non-tumor cells from an MSH2-null individual show altered cell cycle effects post-UVB.
Narine KA; Felton KE; Parker AA; Tron VA; Andrew SE
Oncol Rep; 2007 Dec; 18(6):1403-11. PubMed ID: 17982623
[TBL] [Abstract][Full Text] [Related]
5. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint.
Marquez N; Chappell SC; Sansom OJ; Clarke AR; Court J; Errington RJ; Smith PJ
Oncogene; 2003 Oct; 22(48):7642-8. PubMed ID: 14576827
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 and MSH2 with recombinative repair complexes during S phase.
Zink D; Mayr C; Janz C; Wiesmüller L
Oncogene; 2002 Jul; 21(31):4788-800. PubMed ID: 12101417
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study.
Young LC; Thulien KJ; Campbell MR; Tron VA; Andrew SE
Carcinogenesis; 2004 Oct; 25(10):1821-7. PubMed ID: 15166087
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
Yamane K; Schupp JE; Kinsella TJ
Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.
Pichierri P; Franchitto A; Piergentili R; Colussi C; Palitti F
Carcinogenesis; 2001 Nov; 22(11):1781-7. PubMed ID: 11698339
[TBL] [Abstract][Full Text] [Related]
12. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
13. DNA repair after irradiation in glioma cells and normal human astrocytes.
Short SC; Martindale C; Bourne S; Brand G; Woodcock M; Johnston P
Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360
[TBL] [Abstract][Full Text] [Related]
14. Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers.
Sonneveld E; Vrieling H; Mullenders LH; van Hoffen A
Oncogene; 2001 Jan; 20(4):538-41. PubMed ID: 11313985
[TBL] [Abstract][Full Text] [Related]
15. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
[TBL] [Abstract][Full Text] [Related]
17. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.
Barwell J; Pangon L; Hodgson S; Georgiou A; Kesterton I; Slade T; Taylor M; Payne SJ; Brinkman H; Smythe J; Sebire NJ; Solomon E; Docherty Z; Camplejohn R; Homfray T; Morris JR
J Med Genet; 2007 Aug; 44(8):516-20. PubMed ID: 17483304
[TBL] [Abstract][Full Text] [Related]
18. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
19. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells.
Holt SM; Scemama JL; Panayiotidis MI; Georgakilas AG
Mutat Res; 2009 Mar; 674(1-2):123-30. PubMed ID: 18955159
[TBL] [Abstract][Full Text] [Related]
20. The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase.
Yang Q; Zhang R; Wang XW; Linke SP; Sengupta S; Hickson ID; Pedrazzi G; Perrera C; Stagljar I; Littman SJ; Modrich P; Harris CC
Oncogene; 2004 May; 23(21):3749-56. PubMed ID: 15064730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
